BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26495999)

  • 1. Pediatric investigation plans for specific immunotherapy: Questionable contributions to childhood health.
    Rose K; Kopp MV
    Pediatr Allergy Immunol; 2015 Dec; 26(8):695-701. PubMed ID: 26495999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory environment for allergen-specific immunotherapy.
    Kaul S; May S; Lüttkopf D; Vieths S
    Allergy; 2011 Jun; 66(6):753-64. PubMed ID: 21288251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children.
    Eichler I; Soriano ES
    Allergy; 2011 Aug; 66(8):999-1004. PubMed ID: 21426358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?
    Rose K; Walson PD
    Clin Ther; 2017 Feb; 39(2):253-265. PubMed ID: 28159363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhood.
    Larenas-Linnemann D; Pfaar O
    Curr Opin Allergy Clin Immunol; 2014 Jun; 14(3):192-9. PubMed ID: 24781917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis.
    Pfaar O; Klimek L; Gerth van Wijk R
    Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):197-203. PubMed ID: 25899694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline.
    Gödicke V; Hundt F
    Allergy; 2010 Dec; 65(12):1499-505. PubMed ID: 20608914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).
    Klimek L; Pfaar O; Worm M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1123-35. PubMed ID: 27191353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019.
    Mahler V; Mentzer D; Bonertz A; Muraro A; Eigenmann P; Bousquet J; Halken S; Pfaar O; Jutel M; Wahn U; Vieths S; Kaul S
    Clin Transl Allergy; 2020; 10():28. PubMed ID: 32612805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E; Wahn HU; Didier A; Bachert C
    Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy of allergies: current status].
    Mahler V; Kleine-Tebbe J; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1341-1356. PubMed ID: 33140209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.
    Pajno GB; Nadeau KC; Passalacqua G; Caminiti L; Hobson B; Jay DC; Arasi S; Chiera F; Salzano G
    Expert Rev Clin Immunol; 2015 Jan; 11(1):141-54. PubMed ID: 25454510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation.
    Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A
    Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.